Targeted therapy is?a type of cancer treatment that uses drugs or other substances to precisely identify and attack certain types of cancer cells. A targeted therapy can be used by itself or in combination with other treatments, such as traditional or standard chemotherapy, surgery, or radiation therapy.
This report contains market size and forecasts of Oncology Targeted Therapy in Global, including the following market information:
Global Oncology Targeted Therapy Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Oncology Targeted Therapy market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Sorafenib Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Oncology Targeted Therapy include Bayer, Eisai, Zelgen, Cipla, Natco Pharma, AstraZeneca, Novartis, Roche and Bristol-Myers Squibb, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oncology Targeted Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oncology Targeted Therapy Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Oncology Targeted Therapy Market Segment Percentages, by Type, 2022 (%)
Sorafenib
Lenvatinib
Regorafenib
Osimertinib
Anlotinib
Alectinib
Other
Global Oncology Targeted Therapy Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Oncology Targeted Therapy Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Other
Global Oncology Targeted Therapy Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Oncology Targeted Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oncology Targeted Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Oncology Targeted Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Eisai
Zelgen
Cipla
Natco Pharma
AstraZeneca
Novartis
Roche
Bristol-Myers Squibb
Pfizer
BEACON Pharma
Jiangxi Shanxiang
Yao Pharma
CSPC
CHIATAI Tianqing
Simcere
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Oncology Targeted Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncology Targeted Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncology Targeted Therapy Overall Market Size
2.1 Global Oncology Targeted Therapy Market Size: 2022 VS 2030
2.2 Global Oncology Targeted Therapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oncology Targeted Therapy Players in Global Market
3.2 Top Global Oncology Targeted Therapy Companies Ranked by Revenue
3.3 Global Oncology Targeted Therapy Revenue by Companies
3.4 Top 3 and Top 5 Oncology Targeted Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Oncology Targeted Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oncology Targeted Therapy Players in Global Market
3.6.1 List of Global Tier 1 Oncology Targeted Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Oncology Targeted Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Oncology Targeted Therapy Market Size Markets, 2022 & 2030
4.1.2 Sorafenib
4.1.3 Lenvatinib
4.1.4 Regorafenib
4.1.5 Osimertinib
4.1.6 Anlotinib
4.1.7 Alectinib
4.1.8 Other
4.2 By Type - Global Oncology Targeted Therapy Revenue & Forecasts
4.2.1 By Type - Global Oncology Targeted Therapy Revenue, 2018-2023
4.2.2 By Type - Global Oncology Targeted Therapy Revenue, 2023-2030
4.2.3 By Type - Global Oncology Targeted Therapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oncology Targeted Therapy Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application - Global Oncology Targeted Therapy Revenue & Forecasts
5.2.1 By Application - Global Oncology Targeted Therapy Revenue, 2018-2023
5.2.2 By Application - Global Oncology Targeted Therapy Revenue, 2023-2030
5.2.3 By Application - Global Oncology Targeted Therapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Oncology Targeted Therapy Market Size, 2022 & 2030
6.2 By Region - Global Oncology Targeted Therapy Revenue & Forecasts
6.2.1 By Region - Global Oncology Targeted Therapy Revenue, 2018-2023
6.2.2 By Region - Global Oncology Targeted Therapy Revenue, 2023-2030
6.2.3 By Region - Global Oncology Targeted Therapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Oncology Targeted Therapy Revenue, 2018-2030
6.3.2 US Oncology Targeted Therapy Market Size, 2018-2030
6.3.3 Canada Oncology Targeted Therapy Market Size, 2018-2030
6.3.4 Mexico Oncology Targeted Therapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Oncology Targeted Therapy Revenue, 2018-2030
6.4.2 Germany Oncology Targeted Therapy Market Size, 2018-2030
6.4.3 France Oncology Targeted Therapy Market Size, 2018-2030
6.4.4 U.K. Oncology Targeted Therapy Market Size, 2018-2030
6.4.5 Italy Oncology Targeted Therapy Market Size, 2018-2030
6.4.6 Russia Oncology Targeted Therapy Market Size, 2018-2030
6.4.7 Nordic Countries Oncology Targeted Therapy Market Size, 2018-2030
6.4.8 Benelux Oncology Targeted Therapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Oncology Targeted Therapy Revenue, 2018-2030
6.5.2 China Oncology Targeted Therapy Market Size, 2018-2030
6.5.3 Japan Oncology Targeted Therapy Market Size, 2018-2030
6.5.4 South Korea Oncology Targeted Therapy Market Size, 2018-2030
6.5.5 Southeast Asia Oncology Targeted Therapy Market Size, 2018-2030
6.5.6 India Oncology Targeted Therapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Oncology Targeted Therapy Revenue, 2018-2030
6.6.2 Brazil Oncology Targeted Therapy Market Size, 2018-2030
6.6.3 Argentina Oncology Targeted Therapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oncology Targeted Therapy Revenue, 2018-2030
6.7.2 Turkey Oncology Targeted Therapy Market Size, 2018-2030
6.7.3 Israel Oncology Targeted Therapy Market Size, 2018-2030
6.7.4 Saudi Arabia Oncology Targeted Therapy Market Size, 2018-2030
6.7.5 UAE Oncology Targeted Therapy Market Size, 2018-2030
7 Players Profiles
7.1 Bayer
7.1.1 Bayer Corporate Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Oncology Targeted Therapy Major Product Offerings
7.1.4 Bayer Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.1.5 Bayer Key News
7.2 Eisai
7.2.1 Eisai Corporate Summary
7.2.2 Eisai Business Overview
7.2.3 Eisai Oncology Targeted Therapy Major Product Offerings
7.2.4 Eisai Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.2.5 Eisai Key News
7.3 Zelgen
7.3.1 Zelgen Corporate Summary
7.3.2 Zelgen Business Overview
7.3.3 Zelgen Oncology Targeted Therapy Major Product Offerings
7.3.4 Zelgen Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.3.5 Zelgen Key News
7.4 Cipla
7.4.1 Cipla Corporate Summary
7.4.2 Cipla Business Overview
7.4.3 Cipla Oncology Targeted Therapy Major Product Offerings
7.4.4 Cipla Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.4.5 Cipla Key News
7.5 Natco Pharma
7.5.1 Natco Pharma Corporate Summary
7.5.2 Natco Pharma Business Overview
7.5.3 Natco Pharma Oncology Targeted Therapy Major Product Offerings
7.5.4 Natco Pharma Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.5.5 Natco Pharma Key News
7.6 AstraZeneca
7.6.1 AstraZeneca Corporate Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Oncology Targeted Therapy Major Product Offerings
7.6.4 AstraZeneca Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News
7.7 Novartis
7.7.1 Novartis Corporate Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Oncology Targeted Therapy Major Product Offerings
7.7.4 Novartis Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.7.5 Novartis Key News
7.8 Roche
7.8.1 Roche Corporate Summary
7.8.2 Roche Business Overview
7.8.3 Roche Oncology Targeted Therapy Major Product Offerings
7.8.4 Roche Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.8.5 Roche Key News
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Corporate Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Oncology Targeted Therapy Major Product Offerings
7.9.4 Bristol-Myers Squibb Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.9.5 Bristol-Myers Squibb Key News
7.10 Pfizer
7.10.1 Pfizer Corporate Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Oncology Targeted Therapy Major Product Offerings
7.10.4 Pfizer Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.10.5 Pfizer Key News
7.11 BEACON Pharma
7.11.1 BEACON Pharma Corporate Summary
7.11.2 BEACON Pharma Business Overview
7.11.3 BEACON Pharma Oncology Targeted Therapy Major Product Offerings
7.11.4 BEACON Pharma Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.11.5 BEACON Pharma Key News
7.12 Jiangxi Shanxiang
7.12.1 Jiangxi Shanxiang Corporate Summary
7.12.2 Jiangxi Shanxiang Business Overview
7.12.3 Jiangxi Shanxiang Oncology Targeted Therapy Major Product Offerings
7.12.4 Jiangxi Shanxiang Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.12.5 Jiangxi Shanxiang Key News
7.13 Yao Pharma
7.13.1 Yao Pharma Corporate Summary
7.13.2 Yao Pharma Business Overview
7.13.3 Yao Pharma Oncology Targeted Therapy Major Product Offerings
7.13.4 Yao Pharma Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.13.5 Yao Pharma Key News
7.14 CSPC
7.14.1 CSPC Corporate Summary
7.14.2 CSPC Business Overview
7.14.3 CSPC Oncology Targeted Therapy Major Product Offerings
7.14.4 CSPC Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.14.5 CSPC Key News
7.15 CHIATAI Tianqing
7.15.1 CHIATAI Tianqing Corporate Summary
7.15.2 CHIATAI Tianqing Business Overview
7.15.3 CHIATAI Tianqing Oncology Targeted Therapy Major Product Offerings
7.15.4 CHIATAI Tianqing Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.15.5 CHIATAI Tianqing Key News
7.16 Simcere
7.16.1 Simcere Corporate Summary
7.16.2 Simcere Business Overview
7.16.3 Simcere Oncology Targeted Therapy Major Product Offerings
7.16.4 Simcere Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.16.5 Simcere Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Oncology Targeted Therapy Market Opportunities & Trends in Global Market
Table 2. Oncology Targeted Therapy Market Drivers in Global Market
Table 3. Oncology Targeted Therapy Market Restraints in Global Market
Table 4. Key Players of Oncology Targeted Therapy in Global Market
Table 5. Top Oncology Targeted Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Oncology Targeted Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Oncology Targeted Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Oncology Targeted Therapy Product Type
Table 9. List of Global Tier 1 Oncology Targeted Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oncology Targeted Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Oncology Targeted Therapy Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Oncology Targeted Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Oncology Targeted Therapy Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Oncology Targeted Therapy Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Oncology Targeted Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Oncology Targeted Therapy Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Oncology Targeted Therapy Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Oncology Targeted Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Oncology Targeted Therapy Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Oncology Targeted Therapy Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Oncology Targeted Therapy Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Oncology Targeted Therapy Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Oncology Targeted Therapy Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Oncology Targeted Therapy Revenue, (US$, Mn), 2023-2030
Table 30. Bayer Corporate Summary
Table 31. Bayer Oncology Targeted Therapy Product Offerings
Table 32. Bayer Oncology Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 33. Eisai Corporate Summary
Table 34. Eisai Oncology Targeted Therapy Product Offerings
Table 35. Eisai Oncology Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 36. Zelgen Corporate Summary
Table 37. Zelgen Oncology Targeted Therapy Product Offerings
Table 38. Zelgen Oncology Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 39. Cipla Corporate Summary
Table 40. Cipla Oncology Targeted Therapy Product Offerings
Table 41. Cipla Oncology Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 42. Natco Pharma Corporate Summary
Table 43. Natco Pharma Oncology Targeted Therapy Product Offerings
Table 44. Natco Pharma Oncology Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 45. AstraZeneca Corporate Summary
Table 46. AstraZeneca Oncology Targeted Therapy Product Offerings
Table 47. AstraZeneca Oncology Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 48. Novartis Corporate Summary
Table 49. Novartis Oncology Targeted Therapy Product Offerings
Table 50. Novartis Oncology Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 51. Roche Corporate Summary
Table 52. Roche Oncology Targeted Therapy Product Offerings
Table 53. Roche Oncology Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 54. Bristol-Myers Squibb Corporate Summary
Table 55. Bristol-Myers Squibb Oncology Targeted Therapy Product Offerings
Table 56. Bristol-Myers Squibb Oncology Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 57. Pfizer Corporate Summary
Table 58. Pfizer Oncology Targeted Therapy Product Offerings
Table 59. Pfizer Oncology Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 60. BEACON Pharma Corporate Summary
Table 61. BEACON Pharma Oncology Targeted Therapy Product Offerings
Table 62. BEACON Pharma Oncology Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 63. Jiangxi Shanxiang Corporate Summary
Table 64. Jiangxi Shanxiang Oncology Targeted Therapy Product Offerings
Table 65. Jiangxi Shanxiang Oncology Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 66. Yao Pharma Corporate Summary
Table 67. Yao Pharma Oncology Targeted Therapy Product Offerings
Table 68. Yao Pharma Oncology Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 69. CSPC Corporate Summary
Table 70. CSPC Oncology Targeted Therapy Product Offerings
Table 71. CSPC Oncology Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 72. CHIATAI Tianqing Corporate Summary
Table 73. CHIATAI Tianqing Oncology Targeted Therapy Product Offerings
Table 74. CHIATAI Tianqing Oncology Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 75. Simcere Corporate Summary
Table 76. Simcere Oncology Targeted Therapy Product Offerings
Table 77. Simcere Oncology Targeted Therapy Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Oncology Targeted Therapy Segment by Type in 2022
Figure 2. Oncology Targeted Therapy Segment by Application in 2022
Figure 3. Global Oncology Targeted Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Oncology Targeted Therapy Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Oncology Targeted Therapy Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oncology Targeted Therapy Revenue in 2022
Figure 8. By Type - Global Oncology Targeted Therapy Revenue Market Share, 2018-2030
Figure 9. By Application - Global Oncology Targeted Therapy Revenue Market Share, 2018-2030
Figure 10. By Region - Global Oncology Targeted Therapy Revenue Market Share, 2018-2030
Figure 11. By Country - North America Oncology Targeted Therapy Revenue Market Share, 2018-2030
Figure 12. US Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Oncology Targeted Therapy Revenue Market Share, 2018-2030
Figure 16. Germany Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 17. France Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Oncology Targeted Therapy Revenue Market Share, 2018-2030
Figure 24. China Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 28. India Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Oncology Targeted Therapy Revenue Market Share, 2018-2030
Figure 30. Brazil Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Oncology Targeted Therapy Revenue Market Share, 2018-2030
Figure 33. Turkey Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 37. Bayer Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Eisai Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Zelgen Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Cipla Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Natco Pharma Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AstraZeneca Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Roche Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bristol-Myers Squibb Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Pfizer Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. BEACON Pharma Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Jiangxi Shanxiang Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Yao Pharma Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. CSPC Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. CHIATAI Tianqing Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Simcere Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
